Morepen Laboratories consolidated net profit declines 53.96% in the March 2022 quarter

Sales rise 28.50% to Rs 368.28 crore

Net profit of Morepen Laboratories declined 53.96% to Rs 12.32 crore in the quarter ended March 2022 as against Rs 26.76 crore during the previous quarter ended March 2021. Sales rose 28.50% to Rs 368.28 crore in the quarter ended March 2022 as against Rs 286.60 crore during the previous quarter ended March 2021.

For the full year,net profit rose 4.73% to Rs 101.68 crore in the year ended March 2022 as against Rs 97.09 crore during the previous year ended March 2021. Sales rose 30.20% to Rs 1546.83 crore in the year ended March 2022 as against Rs 1188.06 crore during the previous year ended March 2021.

ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales368.28286.60 28 1546.831188.06 30 OPM %5.0710.61 -8.849.98 - PBDT21.0634.62 -39 154.35128.79 20 PBT14.1827.63 -49 126.7098.51 29 NP12.3226.76 -54 101.6897.09 5

Powered by Capital Market - Live News